Condition

Tumor Markers, Biological

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions3

Lead sponsors shown2

Clinical trials

2 shown

B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.NCT07236177 · 2026-02-03

RECRUITING

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate CancerNCT00748358 · 2008-03-01

COMPLETED

Common interventions

blood plasma sampleBIOLOGICAL1blood samplingBIOLOGICAL1sunitinibDRUG1

Leading sponsors

Assistance Publique - Hôpitaux de Paris1Poitiers University Hospital1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

EARLY_PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.